Drug Trial Radar · NCT03142893
Hormonal Mechanisms of Sleep Restriction - Axis Study
Last checked: Nov 20, 2026Latest source record: Sep 11, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
80
Planned (sponsor's estimate)
Start
May 8, 2017
Primary completion
Oct 30, 2020
Study completion Jun 30, 2026
Sponsor
- Lead sponsor
- Peter y. LiuAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- May 8, 2017
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Basic science
- FDA-regulated drug
- Yes
- Who can join
- Male only, from 22 years, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to 1) determine how hypothalamic-pituitary-adrenal axis (HPA axis) activation occurs with sleep restriction 2) evaluate how hypothalamic-pituitary-gonadal axis (HPG axis) deactivation occurs with sleep restriction. The investigator will also examine the cognitive function associated with sleep restriction, including food intake and food cravings.
Conditions
- Sleep Restriction
Interventions
Ketoconazole PillDrug
Ketoconazole pill is taken 4 times per Inpatient Stay
GanirelixDrug
Ganirelix subcutaneous injection is administered twice per Inpatient Stay
DexamethasoneDrug
Dexamethasone Pills is taken twice per Inpatient Stay
Dexamethasone InjectionDrug
Dexamethasone IV injection is given twice per Inpatient Stay
Cosyntropin Injectable ProductDrug
cosyntropin injection is given twice per Inpatient Stay
Recombinant Human Luteinizing HormoneDrug
Leutinizing-Releasing Hormone is given 6 IV infusion pulses per Inpatient Visit
Hydrocortisone InjectionDrug
Hydrocortisone IV push is given twice per Inpatient Visit
GonadorelinDrug
Gonadorelin IV injection is given twice per Inpatient Stay
CorticorelinDrug
Corticorelin IV injection is given twice per Inpatient Stay
Placebo oral capsuleDrug
Placebo for ketoconazole are given 4 times per Inpatient Stay
Saline SolutionDrug
Saline Solution (Placebo) for Dexamethasone IV injection or hydrocortisone IV injection given up to four times per Inpatient Stay
Saline Solution for InjectionDrug
Saline Solution (placebo) for ganirelix subcutaneous injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Average Blood Cortisol ConcentrationTime frame: 5 days
- Average Blood Testosterone ConcentrationTime frame: 5 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Los Angeles Biomedical Research Institute
Torrance, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.